Neogen Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	8,620	7,776	6,907	6,862	4,873
Revenue Growth (YoY)	10.85%	12.58%	0.65%	40.83%	44.84%
Cost of Revenue	4,665	4,289	3,876	3,940	2,750
Gross Profit	3,955	3,486	3,031	2,922	2,123
Selling, General & Admin	900.8	685.9	659.9	499.6	334.1
Other Operating Expenses	1,681	1,439	1,272	1,307	924.4
Operating Expenses	2,857	2,401	2,159	1,967	1,374
Operating Income	1,098	1,085	871.8	954.2	749
Interest Expense	-751.1	-378.6	-377.8	-237	-178
Interest & Investment Income	-	15.7	74.1	38.3	6
Earnings From Equity Investments	2.8	2	1.8	1	1.8
Other Non Operating Income (Expenses)	61.4	-82	-42.2	-46.2	-12
EBT Excluding Unusual Items	410.8	642.4	527.7	710.3	566.8
Gain (Loss) on Sale of Investments	-	-	-	-	3.9
Other Unusual Items	-	-140.8	-	-	-
Pretax Income	410.8	501.6	527.7	710.3	570.7
Income Tax Expense	123.3	153.3	171.2	210.6	124.4
Net Income	287.5	348.3	356.5	499.7	446.3
Net Income to Common	287.5	348.3	356.5	499.7	446.3
Net Income Growth	-17.46%	-2.30%	-28.66%	11.96%	42.45%
Shares Outstanding (Basic)	26	26	26	25	25
Shares Outstanding (Diluted)	26	26	26	25	25
Shares Change (YoY)	-0.02%	3.29%	2.41%	-	6.88%
EPS (Basic)	10.90	13.20	13.96	20.04	17.90
EPS (Diluted)	10.90	13.20	13.96	20.03	17.90
EPS Growth	-17.42%	-5.43%	-30.31%	11.93%	33.28%
Free Cash Flow	-7,872	-1,217	-3,319	-1,328	-1,689
Free Cash Flow Per Share	-298.45	-46.13	-129.96	-53.27	-67.71
Dividend Per Share	1.000	1.000	2.000	3.000	2.750
Dividend Growth	-	-50.00%	-33.33%	9.09%	22.22%
Gross Margin	45.88%	44.84%	43.88%	42.58%	43.57%
Operating Margin	12.73%	13.96%	12.62%	13.91%	15.37%
Profit Margin	3.33%	4.48%	5.16%	7.28%	9.16%
Free Cash Flow Margin	-91.33%	-15.65%	-48.06%	-19.36%	-34.66%
EBITDA	1,373	1,293	1,054	1,094	848.6
EBITDA Margin	15.93%	16.63%	15.26%	15.95%	17.42%
D&A For EBITDA	275.2	208.1	181.9	140.1	99.6
EBIT	1,098	1,085	871.8	954.2	749
EBIT Margin	12.73%	13.96%	12.62%	13.91%	15.37%
Effective Tax Rate	30.01%	30.56%	32.44%	29.65%	21.80%
Revenue as Reported	8,681	7,816	6,981	6,906	4,883

Source: S&P Global Market Intelligence. Standard template. Financial Sources.